[CAS NO. 191089-60-8]  K-7174dihydrochloride

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [191089-60-8]

Distributor
Catalog
AS952229
Brand
Arctom Scientific
CAS
191089-60-8

DESCRIPTION [191089-60-8]

Overview

MDL-
Molecular Weight641.67
Molecular FormulaC33H50Cl2N2O6
SMILESCOC1=C(OC)C(OC)=CC(/C=C/CCCN2CCN(CCC/C=C/C3=CC(OC)=C(OC)C(OC)=C3)CCC2)=C1.[H]Cl.[H]Cl

For research use only. We do not sell to patients.


Summary

K-7174 dihydrochloride is an orally active proteasome and GATA inhibitor. K-7174 dihydrochloride is a cell adhesion inhibitor. K-7174 dihydrochloride induces cell apoptosis . K-7174 dihydrochloride shows antitumor activities, it can be used for the research of cancer [1] [2] [3] .


In Vitro

K-7174 dihydrochloride (10 μM; 1 h) inhibits the adhesion by VCAM-1 and its ligand [1] .
K-7174 dihydrochloride (1-30 μM; 1 h) dose-dependently suppresses the VCAM-1 expression with an IC 50 value of 14 μM [1] .
K-7174 dihydrochloride (1-30 μM; 1 h) dose-dependently suppresses the induction of VCAM-1 mRNA by TNFα with an IC 50 value of 9 μM [1] .
K-7174 dihydrochloride (10-20 μM; 24 h) dose-dependently rescues Epo production by Hep3B cells [2] .
K-7174 dihydrochloride (2.5-30 μM; 24 h) inhibits the binding activity of GATA [2] .
K-7174 dihydrochloride (0-25 μM; 72 h) inhibits MM cells growth and induces cell apoptosis [3] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay [3]

Cell Line: KMS12-BM, U266, and RPMI8226 cell lines
Concentration: 0-25 μM
Incubation Time: 72 h
Result: Inhibited MM cells growth.

Apoptosis Analysis [3]

Cell Line: KMS12-BM, U266, and RPMI8226 cell lines
Concentration: 10 μM
Incubation Time: 48 h
Result: Significantly increased apoptosis of MM cells with the increasing percentage of annexin-V-positive cells.

In Vivo

K-7174 dihydrochloride (30 mg/kg; i.p. once daily for 9 days) reverses the decreasing of hemoglobin concentrations and reticulocyte counts by IL-1β or TNF-α [2] .
K-7174 dihydrochloride (75 mg/kg; i.p. once daily for 14 days) inhibits the tumor growth in vivo [3] .
K-7174 dihydrochloride (50 mg/kg; p.o. once daily for 14 days) inhibits the tumor growth in vivo and shows a better effect than intraperitoneal injection [3] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: ICR mice with IL-β or TNF-α injection [2]
Dosage: 30 mg/kg
Administration: Intraperitoneal injection; 30 mg/kg once daily for 9 days
Result: Increased erythropoietin (Epo) production, reticulocyte counts, and hemoglobin (Hb) concentrations.
Animal Model: NOD/SCID mice with murine xenograft [3]
Dosage: 75 mg/kg
Administration: Intraperitoneal injection; once daily for 14 days
Result: Significantly decreased tumor volume, but showed a significant body weight reduction after 10 days.
Animal Model: NOD/SCID mice with murine xenograft [3]
Dosage: 50 mg/kg
Administration: Oral gavage; once daily for 14 days
Result: Showed an anti-myeloma activity. Porved oral administration is more effective than intraperitoneal injection.

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

4°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)


Solvent & Solubility

In Vitro:

H 2 O : 15 mg/mL ( 23.38 mM ; Need ultrasonic and warming)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.5584 mL 7.7922 mL 15.5843 mL
5 mM 0.3117 mL 1.5584 mL 3.1169 mL
10 mM 0.1558 mL 0.7792 mL 1.5584 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: PBS

    Solubility: 10 mg/mL (15.58 mM); Clear solution; Need ultrasonic

* All of the co-solvents are available by MCE.


Synonyms

1H-1,4-Diazepine, hexahydro-1,4-bis[(4E)-5-(3,4,5-trimethoxyphenyl)-4-penten-1-yl]-, hydrochloride (1:2)
1H-1,4-Diazepine, hexahydro-1,4-bis[5-(3,4,5-trimethoxyphenyl)-4-pentenyl]-, dihydrochloride, (E,E)-